Differential Activation of Programmed Cell Death in Patients with Severe SARS-CoV-2 Infection
Description
SARS-CoV-2 (SARS-2) causes severe lower airway disease and death in a subset of patients. Knowledge on the relative contribution of programmed cell death (PCD) to lung pathology is limited to few human autopsy studies with small sample size/scope, in
